Literature DB >> 35951138

Expression and characterization of heparinase II with MBP tag from a novel strain, Raoultella NX-TZ-3-15.

Yinyin Li1, Yue Lin1, Yingzi Jiang1, Hafiza Mahreen Mehwish2, Muhammad Shahid Riaz Rajoka3, Liqing Zhao4,5.   

Abstract

The enzymes are biological macromolecules that biocatalyze certain biochemical reactions without undergoing any modification or degradation at the end of the reaction. In this work, we constructed a recombinant novel Raoultella sp. NX-TZ-3-15 strain that produces heparinase with a maltose binding tag to enhance its production and activity. Additionally, MBP-heparinase was purified and its enzymatic capabilities are investigated to determine its industrial application. Moreover, the recombinant plasmid encoding the MBP-heparinase fusion protein was effectively generated and purified to a high purity. According to SDS-PAGE analysis, the MBP-heparinase has a molecular weight of around 70 kDa and the majority of it being soluble with a maximum activity of 5386 U/L. It has also been noted that the three ions of Ca2 + , Co2 + , and Mg2 + can have an effect on heparinase activities, with Mg2 + being the most noticeable, increasing by about 85%, while Cu2 + , Fe2 + , Zn2 + having an inhibitory effect on heparinase activities. Further investigations on the mechanistic action, structural features, and genomes of Raoultella sp. NX-TZ-3-15 heparinase synthesis are required for industrial-scale manufacturing.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Heparinase; MBP tag; Raoultella sp. NX-TZ-3-15; Ultra-low-weight heparin

Mesh:

Substances:

Year:  2022        PMID: 35951138     DOI: 10.1007/s00203-022-03158-4

Source DB:  PubMed          Journal:  Arch Microbiol        ISSN: 0302-8933            Impact factor:   2.667


  20 in total

Review 1.  LMWH and its derivatives represent new rational for cancer therapy: construction strategies and combination therapy.

Authors:  Shi Du; Yao Yu; Cheng Xu; Hui Xiong; Shan Yang; Jing Yao
Journal:  Drug Discov Today       Date:  2019-06-19       Impact factor: 7.851

Review 2.  Advances in the preparation and synthesis of heparin and related products.

Authors:  Sultan N Baytas; Robert J Linhardt
Journal:  Drug Discov Today       Date:  2020-09-16       Impact factor: 7.851

3.  Facile Oriented Immobilization of Histidine-Tagged Proteins on Nonfouling Cobalt Polyphenolic Self-Assembly Surfaces.

Authors:  Lulu Han; Qi Liu; Liwei Yang; Tong Ye; Zhien He; Lingyun Jia
Journal:  ACS Biomater Sci Eng       Date:  2017-11-02

Review 4.  Review: Inhibitory potential of low molecular weight Heparin in cell adhesion; emphasis on tumor metastasis.

Authors:  Umer Ejaz; Fahad Akhtar; Jinbing Xue; Xinyu Wan; Tong Zhang; Shuying He
Journal:  Eur J Pharmacol       Date:  2020-12-01       Impact factor: 4.432

5.  Rational design of a tripartite fusion protein of heparinase I enables one-step affinity purification and real-time activity detection.

Authors:  Ziliang Huang; Fengchun Ye; Chong Zhang; Shuo Chen; Yin Chen; Jingjun Wu; Masahiro Togo; Xin-Hui Xing
Journal:  J Biotechnol       Date:  2012-10-13       Impact factor: 3.307

Review 6.  The use of heparin and heparin-like molecules in cancer treatment: a review.

Authors:  Johnny Atallah; Hussein H Khachfe; Juliett Berro; Hazem I Assi
Journal:  Cancer Treat Res Commun       Date:  2020-07-09

7.  Microbiological quality of ready-to-eat salads: an underestimated vehicle of bacteria and clinically relevant antibiotic resistance genes.

Authors:  Joana Campos; Joana Mourão; Nazaré Pestana; Luísa Peixe; Carla Novais; Patrícia Antunes
Journal:  Int J Food Microbiol       Date:  2013-08-17       Impact factor: 5.277

8.  Molecular profiling and weight determination of heparins and depolymerized heparins.

Authors:  A Ahsan; W Jeske; D Hoppensteadt; J C Lormeau; H Wolf; J Fareed
Journal:  J Pharm Sci       Date:  1995-06       Impact factor: 3.534

9.  Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin.

Authors:  Jack E Ansell; Bryan E Laulicht; Sasha H Bakhru; Maureane Hoffman; Solomon S Steiner; James C Costin
Journal:  Thromb Res       Date:  2016-07-18       Impact factor: 3.944

Review 10.  Fusion tags for protein solubility, purification and immunogenicity in Escherichia coli: the novel Fh8 system.

Authors:  Sofia Costa; André Almeida; António Castro; Lucília Domingues
Journal:  Front Microbiol       Date:  2014-02-19       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.